as 10-03-2025 4:00pm EST
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Founded: | 1983 | Country: | United States |
Employees: | N/A | City: | N/A |
Market Cap: | 80.8M | IPO Year: | 2017 |
Target Price: | N/A | AVG Volume (30 days): | 1.5M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.55 | EPS Growth: | N/A |
52 Week Low/High: | $0.27 - $3.25 | Next Earning Date: | 09-15-2025 |
Revenue: | $18,214,531 | Revenue Growth: | 18.33% |
Revenue Growth (this year): | 19.93% | Revenue Growth (next year): | 32.15% |
HYFT Breaking Stock News: Dive into HYFT Ticker-Specific Updates for Smart Investing
Insider Monkey
12 days ago
Business Wire
14 days ago
The information presented on this page, "HYFT MindWalk Holdings Corp. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.